These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The pharmacology of the anorexic effect of phenylpropanolamine. Wellman PJ Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250 [TBL] [Abstract][Full Text] [Related]
6. Progress report on the anorexia induced by drugs believed to mimic some of the effects of serotonin on the central nervous system. Garattini S; Bizzi A; Codegoni AM; Caccia S; Mennini T Am J Clin Nutr; 1992 Jan; 55(1 Suppl):160S-166S. PubMed ID: 1728827 [TBL] [Abstract][Full Text] [Related]
7. Two novel agents affecting eating through an action on monoaminergic systems. Roncucci R; Miranda GF; Verry M Int J Obes; 1984; 8 Suppl 1():103-17. PubMed ID: 6549508 [TBL] [Abstract][Full Text] [Related]
8. Analysis of dopamine D1 and D2 receptor involvement in d- and l-amphetamine-induced anorexia in rats. Gilbert DB; Cooper SJ Brain Res Bull; 1985 Oct; 15(4):385-9. PubMed ID: 2933127 [TBL] [Abstract][Full Text] [Related]
9. Evidence for the involvement of dopamine D(1) and D(2) receptors in mediating the decrease of food intake during repeated treatment with amphetamine. Chen TY; Duh SL; Huang CC; Lin TB; Kuo DY J Biomed Sci; 2001; 8(6):462-6. PubMed ID: 11702009 [TBL] [Abstract][Full Text] [Related]
10. Cross tolerance between anorectic action and induction of Fos-ir with dexfenfluramine and 5HT1B/2C agonists in rats. Rowland NE; Robertson K; Lo J; Rema E Psychopharmacology (Berl); 2001 Jun; 156(1):108-14. PubMed ID: 11465628 [TBL] [Abstract][Full Text] [Related]
11. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine. Callahan BT; Yuan J; Ricaurte GA Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894 [TBL] [Abstract][Full Text] [Related]
12. Both alpha1-adrenergic and D(1)-dopaminergic neurotransmissions are involved in phenylpropanolamine-mediated feeding suppression in mice. Cheng JT; Kuo DY Neurosci Lett; 2003 Aug; 347(2):136-8. PubMed ID: 12873745 [TBL] [Abstract][Full Text] [Related]
13. Anorectic activity of fluoxetine and norfluoxetine in rats: relationship between brain concentrations and in-vitro potencies on monoaminergic mechanisms. Caccia S; Bizzi A; Coltro G; Fracasso C; Frittoli E; Mennini T; Garattini S J Pharm Pharmacol; 1992 Mar; 44(3):250-4. PubMed ID: 1354734 [TBL] [Abstract][Full Text] [Related]
15. An update on the pharmacology of serotoninergic appetite-suppressive drugs. Garattini S Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 4():S41-8. PubMed ID: 1338385 [TBL] [Abstract][Full Text] [Related]
16. Brain neurotransmitters in food and drug reward. Hoebel BG Am J Clin Nutr; 1985 Nov; 42(5 Suppl):1133-50. PubMed ID: 2865893 [TBL] [Abstract][Full Text] [Related]
17. The effect of propranolol phentolamine and pimozide on drug-induced anorexia in the mouse. Dobrzanski S; Doggett NS Psychopharmacology (Berl); 1979; 66(3):297-300. PubMed ID: 119276 [TBL] [Abstract][Full Text] [Related]
18. Anorectic effect of dehydroepiandrosterone combined with dexfenfluramine or thionisoxetine. Rowland NE; Marshall M; Robertson K Eur J Pharmacol; 2001 May; 419(1):61-4. PubMed ID: 11348631 [TBL] [Abstract][Full Text] [Related]
19. D1 and D2 antagonists reverse the effects of appetite suppressants on weight loss, food intake, locomotion, and rebalance spiking inhibition in the rat NAc shell. Kalyanasundar B; Perez CI; Luna A; Solorio J; Moreno MG; Elias D; Simon SA; Gutierrez R J Neurophysiol; 2015 Jul; 114(1):585-607. PubMed ID: 25972577 [TBL] [Abstract][Full Text] [Related]
20. The roles of brain noradrenaline and dopamine in the anorectic activity of diethylpropion in rats: a comparison with d-amphetamine. Borsini F; Bendotti C; Carli M; Poggesi E; Samanin R Res Commun Chem Pathol Pharmacol; 1979 Oct; 26(1):3-11. PubMed ID: 515507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]